Basic Information
| RNALocate ID: | RLID:11002738 |
| RNA Symbol: | hsa-miR-424-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-424-5p |
| RNA ID: | miRBase:MIMAT0001341 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 23663360 |
| Tissue/Cell Line: | Plasma |
| Method: | Next-generation RNA sequencing |
| Description: | Because the abundance of most miRNAs is low in the exosomes, we defined detectable miRNAs as those that had at least one sequence per million mappable miRNA reads. Accordingly, we detected a total of 593 known miRNAs in the 14 libraries. In each individual library, the number of detectable known miRNAs varied from 380 to 474 with an average of 419 [see Additional file 2]. Data are collected from Additional file 2: Read counts of the miRNAs detected in the 14 libraries (normalized to read number per million mappable miRNA seqeuences). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01002268 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01002269 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01002270 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01002271 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:11002735 | Exosome | Serum | 18589210 |
| RLID:11002736 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11002737 | Exosome | Brain tissue | 23382797 |
| RLID:11002739 | Exosome | Serum | 25349172 |
| RLID-D:11000137 | Exosome | Endothelial cells | |
| RLID-D:11000448 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-424-5p | Splenic marginal zone lymphoma | MNDR-E-MI-48728 |
| MNDR | hsa-miR-424-5p | Oral squamous cell carcinoma | MNDR-E-MI-48729 |
| MNDR | hsa-miR-424-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-48730 |
| MNDR | hsa-miR-424-5p | Ovarian clear cell carcinoma | MNDR-E-MI-48731 |
| MNDR | hsa-miR-424-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-48732 |
| MNDR | hsa-miR-424-5p | Lymphoma | MNDR-E-MI-48733 |
| MNDR | hsa-miR-424-5p | Lymphoma non-hodgkin | MNDR-E-MI-48734 |
| MNDR | hsa-miR-424-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-48735 |
| MNDR | hsa-miR-424-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-48736 |
| MNDR | hsa-miR-424-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-48737 |
| MNDR | hsa-miR-424-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-48738 |
| MNDR | hsa-miR-424-5p | Triple negative breast cancer | MNDR-E-MI-48739 |
| MNDR | hsa-miR-424-5p | Breast cancer luminal | MNDR-E-MI-48740 |
| MNDR | hsa-miR-424-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-48741 |
| MNDR | hsa-miR-424-5p | Dermatomyositis | MNDR-E-MI-48742 |
| MNDR | hsa-miR-424-5p | Prostate cancer | MNDR-E-MI-48743 |
| MNDR | hsa-miR-424-5p | Chronic lymphocytic leukemia | MNDR-E-MI-48744 |
| MNDR | hsa-miR-424-5p | Gastric cancer | MNDR-E-MI-48745 |
| MNDR | hsa-miR-424-5p | Gastric lymphoma | MNDR-E-MI-48746 |
| MNDR | hsa-miR-424-5p | Alzheimer disease | MNDR-E-MI-48747 |
| MNDR | hsa-miR-424-5p | Intracranial aneurysm | MNDR-E-MI-48748 |
| MNDR | hsa-miR-424-5p | Urinary bladder cancer | MNDR-E-MI-48749 |
| MNDR | hsa-miR-424-5p | Dysautonomia familial | MNDR-E-MI-48750 |
| MNDR | hsa-miR-424-5p | Head and neck cancer | MNDR-E-MI-48751 |
| MNDR | hsa-miR-424-5p | Leukemia | MNDR-E-MI-48752 |
| MNDR | hsa-miR-424-5p | Cardiovascular disease | MNDR-E-MI-48753 |
| MNDR | hsa-miR-424-5p | Lung cancer | MNDR-E-MI-48754 |
| MNDR | hsa-miR-424-5p | Down syndrome | MNDR-E-MI-48755 |
| MNDR | hsa-miR-424-5p | Parkinson disease | MNDR-E-MI-48756 |
| MNDR | hsa-miR-424-5p | Breast cancer | MNDR-E-MI-48757 |
| MNDR | hsa-miR-424-5p | Neuroendocrine neoplasia | MNDR-E-MI-48758 |
| MNDR | hsa-miR-424-5p | Pituitary neoplasms | MNDR-E-MI-48759 |
| MNDR | hsa-miR-424-5p | Pancreatic cancer | MNDR-E-MI-48760 |
| MNDR | hsa-miR-424-5p | Melanoma | MNDR-E-MI-48761 |
| MNDR | hsa-miR-424-5p | Rectum adenocarcinoma | MNDR-E-MI-48762 |
| MNDR | hsa-miR-424-5p | Nephroblastoma | MNDR-E-MI-48763 |
| MNDR | hsa-miR-424-5p | Colon cancer | MNDR-E-MI-48764 |
| MNDR | hsa-miR-424-5p | Colon adenocarcinoma | MNDR-E-MI-48765 |
| MNDR | hsa-miR-424-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-48766 |
| MNDR | hsa-miR-424-5p | Ovarian cancer | MNDR-E-MI-48767 |
| MNDR | hsa-miR-424-5p | Prostate adenocarcinoma | MNDR-E-MI-48768 |
| MNDR | hsa-miR-424-5p | Kidney cancer | MNDR-E-MI-48769 |
| MNDR | hsa-miR-424-5p | Carcinoma ductal breast | MNDR-E-MI-48770 |
| MNDR | hsa-miR-424-5p | Glioblastoma | MNDR-E-MI-48771 |
| MNDR | hsa-miR-424-5p | Glioma | MNDR-E-MI-48772 |
| MNDR | hsa-miR-424-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-48773 |
| MNDR | hsa-miR-424-5p | Coronary artery disease | MNDR-E-MI-48774 |
| MNDR | hsa-miR-424-5p | Meningioma | MNDR-E-MI-48775 |
| MNDR | hsa-miR-424-5p | Gastric adenocarcinoma | MNDR-E-MI-48776 |
| MNDR | hsa-miR-424-5p | Pituitary adenoma | MNDR-E-MI-48777 |
| MNDR | hsa-miR-424-5p | Lung squamous cell carcinoma | MNDR-E-MI-48778 |
| MNDR | hsa-miR-424-5p | Lung adenocarcinoma | MNDR-E-MI-48779 |
| MNDR | hsa-miR-424-5p | Adrenocortical cancer | MNDR-E-MI-48780 |
| MNDR | hsa-miR-424-5p | Thyroid carcinoma | MNDR-E-MI-48781 |
| MNDR | hsa-miR-424-5p | Ovarian carcinoma | MNDR-E-MI-48782 |
| MNDR | hsa-miR-424-5p | Pancreatic adenocarcinoma | MNDR-E-MI-48783 |
| MNDR | hsa-miR-424-5p | Brain stem cancer | MNDR-E-MI-48784 |
| MNDR | hsa-miR-424-5p | Cervical cancer | MNDR-E-MI-48785 |
| MNDR | hsa-miR-424-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-48786 |
| MNDR | hsa-miR-424-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-48787 |
| MNDR | hsa-miR-424-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-48788 |
| MNDR | hsa-miR-424-5p | Renal clear cell carcinoma | MNDR-E-MI-48789 |
| MNDR | hsa-miR-424-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-48790 |
| MNDR | hsa-miR-424-5p | Cholangiocarcinoma | MNDR-E-MI-48791 |
| MNDR | hsa-miR-424-5p | Esophageal cancer | MNDR-E-MI-48792 |
| MNDR | hsa-miR-424-5p | Oncocytoma | MNDR-E-MI-48793 |
| MNDR | hsa-miR-424-5p | Synovial sarcoma | MNDR-E-MI-48794 |
| MNDR | hsa-miR-424-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-48795 |
| MNDR | hsa-miR-424-5p | Aortic valve disease | MNDR-E-MI-48796 |
| MNDR | hsa-miR-424-5p | Breast invasive carcinoma | MNDR-E-MI-48797 |
| MNDR | hsa-miR-424-5p | Hepatocellular carcinoma | MNDR-E-MI-48798 |
| MNDR | hsa-miR-424-5p | B-cell lymphoma | MNDR-E-MI-48799 |
| MNDR | hsa-miR-424-5p | Rheumatoid arthritis | MNDR-E-MI-48800 |
| MNDR | hsa-miR-424-5p | T-cell leukemia | MNDR-E-MI-48801 |
| MNDR | hsa-miR-424-5p | Retinoblastoma | MNDR-E-MI-48802 |
| MNDR | hsa-miR-424-5p | Chronic myeloid leukemia | MNDR-E-MI-48803 |
| MNDR | hsa-miR-424-5p | Burkitt lymphoma | MNDR-E-MI-48804 |
| MNDR | hsa-miR-424-5p | Mouth neoplasms | MNDR-E-MI-48805 |
| MNDR | hsa-miR-424-5p | Tonsil cancer | MNDR-E-MI-48806 |
| MNDR | hsa-miR-424-5p | Psoriasis | MNDR-E-MI-48807 |
| MNDR | hsa-miR-424-5p | Skin cutaneous melanoma | MNDR-E-MI-48808 |
| MNDR | hsa-miR-424-5p | Skin melanoma | MNDR-E-MI-48809 |
| MNDR | hsa-miR-424-5p | Acute myelocytic leukemia | MNDR-E-MI-48810 |
| MNDR | hsa-miR-424-5p | Colorectal cancer | MNDR-E-MI-48811 |
| MNDR | hsa-miR-424-5p | Nasopharynx carcinoma | MNDR-E-MI-48812 |
| MNDR | hsa-miR-424-5p | Multiple myeloma | MNDR-E-MI-48813 |
| MNDR | hsa-miR-424-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-48814 |
| MNDR | hsa-miR-424-5p | Cardiomegaly | MNDR-E-MI-48815 |
| MNDR | hsa-miR-424-5p | Nasopharyngeal cancer | MNDR-E-MI-48816 |
| MNDR | hsa-miR-424-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-48817 |
| MNDR | hsa-miR-424-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-48818 |
| MNDR | hsa-miR-424-5p | Venous thromboembolism | MNDR-E-MI-48819 |
| MNDR | hsa-miR-424-5p | Stroke lacunar | MNDR-E-MI-48820 |
| MNDR | hsa-miR-424-5p | Breast cancer her3+ negative | MNDR-E-MI-48821 |
| MNDR | hsa-miR-424-5p | High grade dysplastic nodule | MNDR-E-MI-48822 |
| MNDR | hsa-miR-424-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-48823 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO4 | Homo sapiens | RR00056009 |
TOP